Second radiation treatment for prostate cancer that has returned locally
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a second, short course of high-dose radiation for men whose prostate cancer has come back only in the prostate area after earlier radiation. It aims to control the cancer while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had radiation therapy for prostate cancer before, either after surgery or as your main treatment.
- Your cancer has come back only in the prostate area (no spread to other parts of the body) and you are not on hormone therapy.
- You have no serious long-term bladder or bowel problems from your previous radiation.
- You are generally healthy and able to care for yourself.
- You have good urinary flow (or a low IPSS score).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation implant placed directly into the prostate to treat cancer that has come back after initial treatment. It may offer a targeted option for people whose cancer is only in the prostate area.
This trial studies high-dose radiation (HDR) given after prostate cancer returns only in the prostate/seminal vesicles. It may help by trying to control the cancer when it has not spread elsewhere, using targeted treatment based on MRI and biopsy proof.
This trial tests a second course of radiotherapy for men whose prostate cancer has come back in the prostate after an earlier course of radiotherapy. The goal is to check how well the body tolerates this retreatment, especially regarding side effects, and to see if it can help control the cancer.
This trial tests how well salvage radiation therapy works for prostate cancer that has come back after surgery. It looks at whether adding hormone therapy based on PSA response improves outcomes.
This trial compares two different radiation schedules to treat prostate cancer that returned based on rising PSA blood tests after prostatectomy (prostate removal). If you qualify, it may help you and your team choose a radiation approach with the goal of controlling PSA relapse.
This trial tests a shorter course of radiation therapy (hypofractionated radiotherapy) for men who have already had their prostate removed and still have signs of cancer (like rising PSA). The goal is to see if this can help prevent the cancer from coming back.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.